NIH #R01CA303137
Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma
Active
- Amount
- $700K–$800K
- Period
- 2026-06-05 → 2031-05-31
- PIs
- 2
Awarded at DANA-FARBER CANCER INST
Pratiti Bandopadhayay
Full Professor(heuristic)
Glioma Diagnosis and Treatment · Genetics
Compare more Genetics professors.
h-index61
i10-index119
Publications516
Citations26,078
Grants
4 total · 2 active
NIH #R37CA255245
Targeting vulnerabilities of PPM1D-mutant gliomas
Active
- Amount
- $400K–$500K
- Period
- 2026-02-01 → 2028-01-31
- PIs
- 1
Awarded at DANA-FARBER CANCER INST
NIH #R00CA201592
Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma
- Amount
- $200K–$300K
- Period
- 2018-05-03 → 2021-04-30
- PIs
- 1
Awarded at DANA-FARBER CANCER INST
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Supplementary Table S2 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study2026-06-17
- New NIH award: Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma2026-06-05
- New NIH award: Targeting vulnerabilities of PPM1D-mutant gliomas2026-02-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0002-4175-4760